MCM6 and breast carcinoma: On the contrary, WGCNA combining with TCGA and GEO analysis identified that exceptional expression of MCM6 reflects pathologic stage of multiple tumors, serving as putative biomarkers for breast cancer,285, 286, 287 gastric cancer,288, 289 renal cell carcinoma,215, 290, 291 HCC,292, 293, 294, 295 and non‐small cell lung carcinoma.217, 296, 297